NCT07663045

Brief Summary

Marginal bone preservation is an important determinant of long-term implant success. Conventional flap implant placement provides direct visualization of the surgical site but may disturb the periosteal blood supply and contribute to early crestal bone remodeling. Flapless guided implant placement is a minimally invasive approach that aims to preserve soft tissue architecture and vascular integrity. CBCT allows three-dimensional evaluation of peri implant bone levels, including mesial, distal, buccal, and lingual aspects. Aim: The aim of this study was to compare flapless guided implant placement with conventional flap implant placement in terms of marginal bone loss, implant stability, postoperative pain, and soft-tissue healing.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2025

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

June 17, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 23, 2026

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2026

Completed
Last Updated

June 23, 2026

Status Verified

June 1, 2026

Enrollment Period

1 year

First QC Date

June 17, 2026

Last Update Submit

June 17, 2026

Conditions

Keywords

CBCT

Outcome Measures

Primary Outcomes (1)

  • Marginal Bone Loss

    CBCT assessment

    baseline, 3 months, 6 months

Secondary Outcomes (2)

  • Implant Stability ISQ

    baseline, 3 months, 6 months

  • Postoperative Pain Assessment VAS scale 0-10

    baseline, Day 2 Day 3 Day 4 Day 5

Study Arms (2)

Flapless Guided Implant Placement

EXPERIMENTAL
Procedure: Flapless guided implant

Conventional Flap Implant Placement

EXPERIMENTAL
Procedure: Conventional Flap Implant Placement

Interventions

manually raising the gingival tissue during dental implant surgery, this surgical procedure involves the placement of a dental implant directly into the alveolar or basal bone during a single session followed by the placement of a healing abutment without the use of surgical guides or advanced technology.

Conventional Flap Implant Placement

a minimally invasive dental implant procedure where a surgical guide, often created using advanced imaging techniques like cone-beam computed tomography (CBCT) and computer-aided design (CAD), directs the precise placement of dental implants without the need for traditional flap elevation.

Flapless Guided Implant Placement

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 20 years or older.
  • Patients requiring at least two dental implants within the same arch.
  • Patients with good general health and able to undergo oral surgery.
  • Patients willing to participate in the study and provide informed consent.
  • Patients with adequate bone volume for implant placement as determined by preoperative radiographic assessment (e.g., cone beam computed tomography).

You may not qualify if:

  • Patients with systemic diseases that could compromise healing or implant success (e.g., uncontrolled diabetes, immunocompromised conditions).
  • Patients with a history of radiation therapy to the head and neck region.
  • Patients with active periodontal disease or untreated oral infections.
  • Patients who are pregnant or breastfeeding.
  • Patients with a history of bisphosphonate therapy or other medications that may affect bone metabolism.
  • Smoker Patients with a history of smoking or heavy alcohol consumption.
  • Patients with unrealistic expectations or inability to comply with postoperative care instructions.
  • Patients with significant facial trauma or anatomical deformities affecting the implant site.
  • Patient who requires Immediate implant placement
  • Thin gingival biotype

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulf Medical University

Ajman, Ajman Emirate, 00000, United Arab Emirates

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Split mouth design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2026

First Posted

June 23, 2026

Study Start

July 1, 2025

Primary Completion

July 1, 2026

Study Completion

July 30, 2026

Last Updated

June 23, 2026

Record last verified: 2026-06

Locations